223 related articles for article (PubMed ID: 28807056)
1. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
2. Rational design of anti-GITR-based combination immunotherapy.
Zappasodi R; Sirard C; Li Y; Budhu S; Abu-Akeel M; Liu C; Yang X; Zhong H; Newman W; Qi J; Wong P; Schaer D; Koon H; Velcheti V; Hellmann MD; Postow MA; Callahan MK; Wolchok JD; Merghoub T
Nat Med; 2019 May; 25(5):759-766. PubMed ID: 31036879
[TBL] [Abstract][Full Text] [Related]
3. A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma.
Nguyen HM; Oladejo M; Paulishak W; Wood LM
Cancer Immunol Immunother; 2023 Sep; 72(9):2889-2903. PubMed ID: 36562824
[TBL] [Abstract][Full Text] [Related]
4. Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
Hannan R; Zhang H; Wallecha A; Singh R; Liu L; Cohen P; Alfieri A; Rothman J; Guha C
Cancer Immunol Immunother; 2012 Dec; 61(12):2227-38. PubMed ID: 22644735
[TBL] [Abstract][Full Text] [Related]
5. Development of a Listeria monocytogenes based vaccine against prostate cancer.
Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
[TBL] [Abstract][Full Text] [Related]
6. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.
Amoozgar Z; Kloepper J; Ren J; Tay RE; Kazer SW; Kiner E; Krishnan S; Posada JM; Ghosh M; Mamessier E; Wong C; Ferraro GB; Batista A; Wang N; Badeaux M; Roberge S; Xu L; Huang P; Shalek AK; Fukumura D; Kim HJ; Jain RK
Nat Commun; 2021 May; 12(1):2582. PubMed ID: 33976133
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
Ghouse SM; Vadrevu SK; Manne S; Reese B; Patel J; Patel B; Silwal A; Lodhi N; Paterson Y; Srivastava SK; Karbowniczek M; Markiewski MM
J Immunol; 2020 Feb; 204(4):990-1000. PubMed ID: 31900334
[TBL] [Abstract][Full Text] [Related]
8. Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model.
Liu JJ; Su QD; Yi Y; Shen LP; Bi SL
Biomed Environ Sci; 2024 Feb; 37(2):187-195. PubMed ID: 38582981
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.
Ferencz B; Török K; Pipek O; Fillinger J; Csende K; Lantos A; Černeková R; Mitták M; Škarda J; Delongová P; Megyesfalvi E; Schelch K; Lang C; Solta A; Boettiger K; Brcic L; Lindenmann J; Rényi-Vámos F; Aigner C; Berta J; Megyesfalvi Z; Döme B
Cancer Immunol Immunother; 2024 May; 73(6):114. PubMed ID: 38693435
[TBL] [Abstract][Full Text] [Related]
10. Clinical Experience and Recent Advances in the Development of
Oladejo M; Paterson Y; Wood LM
Front Immunol; 2021; 12():642316. PubMed ID: 33936058
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG.
Confino H; Schmidt M; Efrati M; Hochman I; Umansky V; Kelson I; Keisari Y
Cancer Immunol Immunother; 2016 Oct; 65(10):1149-58. PubMed ID: 27495172
[TBL] [Abstract][Full Text] [Related]
12. Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases.
Milette S; Hashimoto M; Perrino S; Qi S; Chen M; Ham B; Wang N; Istomine R; Lowy AM; Piccirillo CA; Brodt P
Nat Commun; 2019 Dec; 10(1):5745. PubMed ID: 31848339
[TBL] [Abstract][Full Text] [Related]
13. Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.
Davis RJ; Van Waes C; Allen CT
Oral Oncol; 2016 Jul; 58():59-70. PubMed ID: 27215705
[TBL] [Abstract][Full Text] [Related]
14. CD8
Palmeri JR; Lax BM; Peters JM; Duhamel L; Stinson JA; Santollani L; Lutz EA; Pinney W; Bryson BD; Dane Wittrup K
Nat Commun; 2024 Mar; 15(1):1900. PubMed ID: 38429261
[TBL] [Abstract][Full Text] [Related]
15. Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody.
Saxena R; Bushey RT; Campa MJ; Gottlin EB; Guo J; Patz EF; He YW
J Immunol; 2024 May; 212(10):1589-1601. PubMed ID: 38558134
[TBL] [Abstract][Full Text] [Related]
16. Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection.
Anderson TS; McCormick AL; Daugherity EA; Oladejo M; Okpalanwaka IF; Smith SL; Appiah D; Wood LM; Lowe DB
Oncoimmunology; 2023; 12(1):2260620. PubMed ID: 37781234
[TBL] [Abstract][Full Text] [Related]
17. GITR activation
Gubser C; Pascoe RD; Chang J; Chiu C; Solomon A; Cao R; Rasmussen TA; Lewin SR
iScience; 2023 Nov; 26(11):108165. PubMed ID: 38026168
[TBL] [Abstract][Full Text] [Related]
18. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy: reengineering tumor immunity.
Chen G; Emens LA
Cancer Immunol Immunother; 2013 Feb; 62(2):203-16. PubMed ID: 23389507
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment.
Xu X; Gan M; Ge Y; Yi C; Feng T; Liu M; Wu C; Chen X; Zhang W; Zhao L; Zou J
J Nanobiotechnology; 2021 Nov; 19(1):376. PubMed ID: 34794428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
